Page last updated: 2024-10-26

etidronate and Anemia, Sickle Cell

etidronate has been researched along with Anemia, Sickle Cell in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Duzee, BF1
Sunberg, RJ1
Benedict, JJ1
Dhekne, RD1

Other Studies

2 other studies available for etidronate and Anemia, Sickle Cell

ArticleYear
Effect of etidronate disodium on filterability of sickle cell erythrocytes.
    Journal of pharmaceutical sciences, 1980, Volume: 69, Issue:5

    Topics: Anemia, Sickle Cell; Cyanates; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes,

1980
Splenic concentration of bone imaging agents in functional asplenia.
    Clinical nuclear medicine, 1981, Volume: 6, Issue:7

    Topics: Adult; Anemia, Sickle Cell; Bone and Bones; Etidronic Acid; Female; Humans; Male; Organotechnetium C

1981